Skip to main content
SENATE 64115th CongressReferred to the Committee on the Judiciary. (text of measure as introduced: CR S1398)

A resolution congratulating the Plastics Industry Association on its 80th anniversary.

Last Action
2/17/2017

Actions

  • 2017-01-09Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • 2017-01-09Introduced in Senate

CRS Summary

As of 2017-01-09 (00)

Safe and Affordable Drugs from Canada Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:

  • is dispensed by a pharmacist licensed in Canada;
  • is purchased for personal use in quantities not greater than a 90-day supply;
  • is filled using a valid prescription issued by a physician licensed to practice in the United States; and
  • has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA.

Certain medications may not be imported, including controlled substances and biological products.

The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.

Subjects

  • Administrative law and regulatory procedures
  • Canada
  • Department of Health and Human Services
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Prescription drugs
  • Trade restrictions
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.